Skip to main content
Log in

Advances in Primary CNS Lymphoma: Randomized Clinical Trials of Chemotherapy and Whole-Brain Radiotherapy

  • Clinical Trial Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Morris PG, Abrey LE. Therapeutic challenges in primary CNS lymphoma. Lancet Neurol. 2009;8:581–92.

    Article  PubMed  CAS  Google Scholar 

  2. Ferreri AJ, Reni M, Pasini F, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology. 2002;58:1513–20.

    PubMed  CAS  Google Scholar 

  3. Jahnke K, Thiel E, Martus P, et al. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol. 2006;80:159–65.

    Article  PubMed  Google Scholar 

  4. Jahnke K, Korfel A, Martus M, et al. High dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol. 2005;16:45–9.

    Google Scholar 

  5. Fischer L, Jahnke K, Martus M, et al. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphoma. Haematologica. 2006;91:429–30.

    PubMed  Google Scholar 

  6. Fischer L, Martus P, Weller M, et al. Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology. 2008;71:1102–8.

    Article  PubMed  CAS  Google Scholar 

  7. Joerger M, Huitema AD, Krähenbühl S, et al. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: a pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. Br J Cancer. 2010;102:673–7.

    Article  PubMed  CAS  Google Scholar 

  8. Cheson BD, Pfistner B, Juweid ME, et al. International harmonization project on lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–86.

    Article  PubMed  Google Scholar 

  9. Pels H, Juergens A, Glasmacher A, et al. Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. J Neurooncol. 2009;91(3):299–305.

    Article  PubMed  CAS  Google Scholar 

  10. Abrey LE, Batchelor TT, Ferreri AJM, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary central nervous system lymphoma. J Clin Oncol. 2005;23:5034–43.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lauren E. Abrey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abrey, L.E. Advances in Primary CNS Lymphoma: Randomized Clinical Trials of Chemotherapy and Whole-Brain Radiotherapy. Curr Neurol Neurosci Rep 11, 243–245 (2011). https://doi.org/10.1007/s11910-011-0183-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-011-0183-1

Keywords

Navigation